Stay updated on Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Sign up to get notified when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.

Latest updates to the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page
- Check7 days agoChange DetectedRemoved related topics links for Ovarian cancer and MedlinePlus Genetics from the Related Topics section.SummaryDifference0.2%

- Check14 days agoChange DetectedOvarian cancer and MedlinePlus Genetics related topics were added as related topics on the page.SummaryDifference0.2%

- Check21 days agoChange DetectedRevision: v3.3.2 appears and ovarian cancer-related topics, MedlinePlus Genetics, and Revision: v3.2.0 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedThe funding-warning notice about government operating status was removed from the study page, a non-substantive site-wide notification. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedOnly minor layout and styling adjustments are visible between the two screenshots; the core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpgrade notice added with operating status guidance and new version v3.2.0; previous version v3.1.0 removed.SummaryDifference4%

Stay in the know with updates to Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Re-sensitizing Carboplatin-Resistant Ovarian Cancer: FAK Clinical Trial page.